DiaMedica Therapeutics Inc

DMAC NASDAQ Santé & Biotech États-Unis CA25253X2077
5.77 $
0.87 %

DiaMedica Therapeutics Inc se concentre sur le développement de traitements pour les maladies neurologiques et rénales à travers des approches biopharmaceutiques uniques.

Performance & Momentum

6 Months 27.88 %
1 Year 42.47 %
3 Years 106.07 %
5 Years 16.26 %

Similar stocks to DiaMedica Therapeutics Inc

Anantys Community

Be the first to share your analysis on DiaMedica Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases